Subtype
Head and Neck Carcinoma
CI-CAN-00000950Explore in graph →
1,014 active trials15 approved drugs119 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000950Explore in graph →
Clinical trials
2,923 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (347)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04447326 | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma | unknown | Phase 2 | 106 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | Jun 25, 2020 | clinicaltrials |
| NCT04447612 | Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 118 | The University of Hong KongOTHER | 1 | Jun 25, 2020 | clinicaltrials |
| NCT02726503 | Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer(HOPE) | completed | Phase 2 | 39 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT00341146 | Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) | completed | — | 6,490 | National Cancer Institute (NCI)NIH | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04163029 | Oral Care Study of Postoperative Infections | unknown | — | 50 | University of LiegeOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04303975 | The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma | unknown | — | 300 | Jiarong Chen, MDOTHER | 0 | Jun 11, 2020 | clinicaltrials |
| NCT04424485 | Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy | unknown | N/A | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04421469 | Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC | unknown | Phase 2 | 39 | Fujian Cancer HospitalOTHER_GOV | 1 | Jun 9, 2020 | clinicaltrials |
| NCT04419324 | To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer | unknown | N/A | 40 | Chinese University of Hong KongOTHER | 0 | Jun 5, 2020 | clinicaltrials |
| NCT04414566 | Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 562 | West China HospitalOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04411290 | Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases | unknown | — | 200 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 2, 2020 | clinicaltrials |
| NCT03874741 | SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 25 | Sinocelltech Ltd.INDUSTRY | 1 | May 27, 2020 | clinicaltrials |
| NCT04399785 | Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC | unknown | Phase 2 | 34 | Xingchen PengOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT04396912 | Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort | unknown | — | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | May 21, 2020 | clinicaltrials |
| NCT04397341 | Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck | completed | Phase 2 | 58 | China Medical University HospitalOTHER | 0 | May 21, 2020 | clinicaltrials |
| NCT04394091 | Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma Patients | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT00181220 | Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma | withdrawn | Phase 1 | 0 | Johns Hopkins UniversityOTHER | 1 | May 18, 2020 | clinicaltrials |
| NCT00367718 | Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma | withdrawn | Phase 2 | 0 | Johns Hopkins UniversityOTHER | 2 | May 18, 2020 | clinicaltrials |
| NCT04387682 | Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients | unknown | N/A | 130 | National Taiwan University HospitalOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT01192815 | Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck | terminated | Phase 2 | 2 | Case Comprehensive Cancer CenterOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04061278 | A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients | unknown | Phase 3 | 246 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT01643499 | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | completed | Phase 1 | 79 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02111460 | Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 126 | Sun Yat-sen UniversityOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT01440270 | Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | completed | Phase 2 | 145 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT02236936 | Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck(AGMT_HNO_PN) | terminated | Phase 3 | 8 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT03670342 | Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer | completed | — | 20 | National Cancer Centre, SingaporeOTHER | 1 | Apr 30, 2020 | clinicaltrials |
| NCT04361409 | Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 1 | 10 | China Medical University HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04351282 | SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma | unknown | N/A | 43 | Fudan UniversityOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT00609284 | Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux(2007-01) | completed | Phase 3 | 406 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Apr 15, 2020 | clinicaltrials |
| NCT03433027 | A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 16 | Benitec Biopharma, Inc.INDUSTRY | 2 | Apr 15, 2020 | clinicaltrials |
| NCT03440151 | Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma | unknown | N/A | 64 | Cairo UniversityOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT01344356 | Stereotactic Body Radiotherapy for Head and Neck Tumors | completed | Phase 4 | 19 | Mercy ResearchOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT01831089 | Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors | completed | Phase 1 | 69 | PharmaMarINDUSTRY | 3 | Apr 10, 2020 | clinicaltrials |
| NCT04336696 | Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? | unknown | N/A | 199 | Bassem Mohamed SiedaOTHER_GOV | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03689556 | Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy | unknown | — | 40 | Shanghai Proton and Heavy Ion CenterOTHER | 0 | Apr 6, 2020 | clinicaltrials |
| NCT03132727 | Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer(Larynx MRI) | completed | — | 73 | Hospices Civils de LyonOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT03211117 | Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer | completed | Phase 2 | 3 | Mayo ClinicOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT04319471 | Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 70 | Fujian Cancer HospitalOTHER_GOV | 1 | Mar 24, 2020 | clinicaltrials |
| NCT03246659 | Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC(GRAN-T-MTC) | completed | Phase 1 | 16 | Paola Anna ErbaOTHER | 5 | Mar 20, 2020 | clinicaltrials |
| NCT00957853 | Preoperative Treatment With Cetuximab and/or IMC-A12 | completed | Phase 2 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT01044433 | Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck | completed | Phase 2 | 44 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT01254617 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC) | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2020 | clinicaltrials |
| NCT02658513 | Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | completed | — | 35 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT02452424 | A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors | terminated | Phase 1 / Phase 2 | 78 | Daiichi SankyoINDUSTRY | 1 | Mar 5, 2020 | clinicaltrials |
| NCT04296747 | Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer | unknown | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 0 | Mar 5, 2020 | clinicaltrials |
| NCT03663985 | FALCOn (Facteur AnthropoLogique Cancer Orl)(FALCOn) | completed | — | 206 | Institut Claudius RegaudOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT01697800 | A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | completed | Phase 2 | 40 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT00625846 | Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer | completed | Phase 2 | 152 | National Cancer Institute (NCI)NIH | 5 | Feb 26, 2020 | clinicaltrials |
| NCT03261180 | Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer | withdrawn | N/A | 0 | OHSU Knight Cancer InstituteOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT01469429 | Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. | completed | Phase 1 / Phase 2 | 70 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 20, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Jun 25, 2020source: clinicaltrials